Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Operating Expenses | 229 | 74 | 961 | 1,952 | 2,640 |
| Operating Income | -229 | -74 | -961 | -1,952 | -2,640 |
| Other Income | 436 | 39 | 23 | -294 | 115 |
| Pre-tax Income | 207 | -35 | -938 | -2,246 | -2,525 |
| Net Income Continuous | 207 | -35 | -938 | -2,246 | -2,525 |
| Net Income | $207 | $-35 | $-938 | $-2,246 | $-2,525 |
| EPS Basic Total Ops | 1.08 | -0.54 | -0.54 | -1.08 | -1.08 |
| EPS Basic Continuous Ops | 0.09 | -0.01 | -0.39 | -0.95 | -1.06 |
| EPS Diluted Total Ops | 1.08 | -0.54 | -0.54 | -1.08 | -1.08 |
| EPS Diluted Continuous Ops | 0.09 | -0.01 | -0.39 | -0.95 | -1.06 |
| EBITDA(a) | $-420 | $-397 | $-961 | $-1,976 | $-2,627 |